IM
Immunome, Inc.
IMNM · NASDAQ
$23.93 -0.71% (-$0.17)
1M -21.35%
Market Cap $2.29B
P/E Ratio -
Div. Yield -
ROE 50.56%
Piotroski F-Score Weak
2/9Valuation
46 /100
Fair P/B 4.36x
PEG N/A
P/E N/A
Growth
100 /100
Growing Book val. growth 236.47%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 44.98%
ROIC 51.06%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 15.08x
Debt/Equity 0.01x
Debt/Assets N/A
Stability
10 /100
Unstable Profitable years 0
Beta 2.13x
EPS volatility 63.65%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre IMNM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Clay Siegall
Employees
247
Headquarters
Bothell
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report